Answers are grounded in this paper and cite their sources.
AZ administration was associated with a 1.99-fold (95% confidence intervals [CI] 1.33-2.97) increase in colonization by B. infantis. B. infantis colonization was highest when inflammatory biomarker levels were within normal range. Mode of delivery (RR 2.43; 95% CI: 1.58, 3.76) and colostrum (RR2.05; 95% CI: 1.41, 2.98) given to the infant within 24 h of birth were associated with B. infantis colonization. A single dose of AZ on day 42 reduced bacterial enteropathogen count in the AZ group on day 56, as compared to the pre-AZ count. Bacterial enteropathogen count for infants with wasting (weight for length z-score WLZ <-2) was 1.43-fold higher (95% CI: 1.00-2.03) than for infants with WLZ ≥ -2. Over 60% of infants harbored with the macrolide resistance mph(A) gene CONCLUSION: AZ administration increases B. infantis colonization and reduces bacterial enteropathogen count in infants.
No takes yet. Share an insight, caveat, or question.
Pasha et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: